Cargando…

Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysis

Immune checkpoint molecules are important targets in cancer immunotherapy, but their association with prognosis in patients with head and neck cancer is controversial. In this meta-analysis, we searched for 12 immune checkpoint molecules in the PubMed, Embase and Cochrane Library databases and retri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Yi-Qun, Yang, Bo, Wen, Li-Ling, Mu, Wen-Xin, Wang, Zhi, Cheng, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366990/ https://www.ncbi.nlm.nih.gov/pubmed/30668545 http://dx.doi.org/10.18632/aging.101756

Ejemplares similares

Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma
por: Zou, Wen-Qing, et al.
Publicado: (2022)

Prognostic value of immune checkpoint molecules in breast cancer
por: Fang, Jun, et al.
Publicado: (2020)

Immune Checkpoint Inhibition in Head and Neck Cancer
por: Forster, Martin David, et al.
Publicado: (2018)

Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Sakai, Akihiro, et al.
Publicado: (2023)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
por: Lechner, Axel, et al.
Publicado: (2017)

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2022)

Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis
por: Fan, Zhaona, et al.
Publicado: (2017)

Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers
por: Suzuki, Susumu, et al.
Publicado: (2020)

Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis
por: Wang, Yanting, et al.
Publicado: (2021)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
por: Veigas, Florencia, et al.
Publicado: (2021)

The predictive and prognostic value of weight loss and body composition prior to and during immune checkpoint inhibition in recurrent or metastatic head and neck cancer patients
por: Willemsen, Anna C. H., et al.
Publicado: (2022)

Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma
por: Xu, Qing-Qing, et al.
Publicado: (2021)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer
por: Chung, Chih‐Hung, et al.
Publicado: (2023)

Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Manukian, Gregor, et al.
Publicado: (2019)

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
por: Qiu, Shijie, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer
por: O’Meara, Connor H., et al.
Publicado: (2023)

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
por: Oliva, M, et al.
Publicado: (2019)

Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma
por: Xu, Qing-Qing, et al.
Publicado: (2023)

Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis
por: Kumarasamy, Chellan, et al.
Publicado: (2019)

Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Dong, Yanbo, et al.
Publicado: (2020)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
por: Valero, Cristina, et al.
Publicado: (2023)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma
por: Han, Ming-Zhi, et al.
Publicado: (2019)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
por: Wang, Haiyang, et al.
Publicado: (2019)

Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
por: dos Santos, Lucas V., et al.
Publicado: (2021)

Rational Combinations of Targeted Therapy and Immune Checkpoint Inhibitors in Head and Neck Cancers
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2022)

Prognostic Value of the Overexpression of Fatty Acid Metabolism-Related Enzymes in Squamous Cell Carcinoma of the Head and Neck
por: Su, Ying-Wen, et al.
Publicado: (2020)

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
por: Shen, Yiming, et al.
Publicado: (2022)

Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy
por: Murakami, Naoya, et al.
Publicado: (2019)

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
por: Zou, Xue-lin, et al.
Publicado: (2021)

Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide
por: Tseng, Jen-Chih, et al.
Publicado: (2021)

The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study
por: Yang, Hang, et al.
Publicado: (2015)

Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: A meta-analysis
por: Yang, Bin, et al.
Publicado: (2016)

Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice
por: Wang, Hui-Ching, et al.
Publicado: (2020)

Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
por: Yao, Yao, et al.
Publicado: (2020)

Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer
por: Feng, Bohai, et al.
Publicado: (2021)

Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol
por: Kumarasamy, Chellan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l96ctag6ib2dtge4rmigl7qcvn